These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21248259)

  • 1. B lymphocytes differentially influence acute and chronic allograft rejection in mice.
    DiLillo DJ; Griffiths R; Seshan SV; Magro CM; Ruiz P; Coffman TM; Tedder TF
    J Immunol; 2011 Feb; 186(4):2643-54. PubMed ID: 21248259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
    Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
    Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation.
    Marino J; Paster JT; Trowell A; Maxwell L; Briggs KH; Crosby Bertorini P; Benichou G
    Am J Transplant; 2016 Feb; 16(2):672-8. PubMed ID: 26552037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
    J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of intra-graft B cells during renal allograft rejection.
    Zarkhin V; Kambham N; Li L; Kwok S; Hsieh SC; Salvatierra O; Sarwal MM
    Kidney Int; 2008 Sep; 74(5):664-73. PubMed ID: 18547992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
    DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
    J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
    Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
    J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells.
    Molinero LL; Zhou P; Wang Y; Harlin H; Kee B; Abraham C; Alegre ML
    Am J Transplant; 2008 Jan; 8(1):21-31. PubMed ID: 18021281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19: a promising B cell target for rheumatoid arthritis.
    Tedder TF
    Nat Rev Rheumatol; 2009 Oct; 5(10):572-7. PubMed ID: 19798033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene.
    Thomas-Vaslin V; Bellier B; Cohen JL; Boyer O; Raynal-Raschilas N; Glotz D; Klatzmann D
    Transplantation; 2000 May; 69(10):2154-61. PubMed ID: 10852616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process.
    Piccotti JR; Li K; Chan SY; Eichwald EJ; Bishop DK
    Transplantation; 1999 Jun; 67(12):1548-55. PubMed ID: 10401761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
    Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
    Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.